State VA
Clinical Trials in Virginia
Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Virginia
NCT07116876 N/A
Recruiting
Matrion Decellularized Placental Membrane Versus Conventional Wound Management i...
Condition
Diabetic Foot Ulcer (DFU)
Enrollment
120 pts
Location
United States
Sponsor
LifeNet Health
NCT06817382 Phase 1
Recruiting
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (I...
Condition
Duchenne Muscular Dystrophy
Enrollment
12 pts
Location
United States
Sponsor
Insmed Gene Therapy LLC
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT06831383 N/A
Recruiting
The STOP-HPV Scale Up Study
Condition
Human Papilloma Virus Vaccine
Enrollment
100,000 pts
Location
United States
Sponsor
University of California, Los
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT06991556 Phase 2
Recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone ...
Condition
Metastatic Hormone-sensitive Prostate Cancer
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
NCT05422690 Phase 2
Recruiting
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin...
Condition
Intrahepatic Cholangiocarcinoma
Enrollment
16 pts
Location
United States
Sponsor
Inova Health Care Services
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT07349537 Phase 1
Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
574 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT07155174 Phase 2
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activ...
Condition
Small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
66 pts
Location
United States, Australia, Belgium
Sponsor
BicycleTx Limited
NCT06601322 N/A
Recruiting
Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony ...
Condition
Left Branch Bundle Block
Enrollment
20 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT06810323 N/A
Recruiting
The ROAM Research Study Therapy (LTOT) Version
Condition
Pulmonary Disease, Chronic Obstructive
Enrollment
100 pts
Location
United States
Sponsor
University of Virginia
NCT04916327 N/A
Recruiting
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals...
Condition
Peripheral Vascular Diseases
Enrollment
720 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT07207369 Phase 3
Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Ad...
Condition
Acne Scars
Enrollment
395 pts
Location
United States
Sponsor
AbbVie
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT03193151 N/A
Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Condition
Liver Dysfunction
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT05871970 Phase 2
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic...
Condition
Lymphatic Malformation
Enrollment
38 pts
Location
United States
Sponsor
Protara Therapeutics
NCT06273683 N/A
Recruiting
Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesa...
Condition
Permanent Sterilization
Enrollment
900 pts
Location
United States
Sponsor
Inova Health Care Services